CancerProfile
Start a new DMP in Loading
The CancerProfile multidisciplinary project brings together highly complementary translational research institutes to develop a novel standard of patient stratification for predictive and personalized medicine of pancreatic adenocarcinoma cancer. The overall objective is to fully integrate cutting-edge AI-augmented anatomopathology, genomics, and tissue/liquid biopsy analysis in conjunction with functional drug response of tumors, to derive biomarkers indicative of a predictive treatment choice. We will apply an innovative Personalized Functional Profiling (PFP) proprietary technology consisting of direct large-scale analysis of the sensitivity of 3D-printed spheroids derived from patient biopsies in response to a panel of EMA and FDA approved anti-cancer chemotherapeutics. Overall, the objective is to clinically validate new prognostic markers and identify alternative treatment options for tumors resistant to standard chemotherapies.
<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=anr_________::8dc4645ceeaa200057ccd6975e89e634&type=result"></script>');
-->
</script>